You are here

F2G

F2G raises $100M to bring antifungal drug back to FDA

BioPharma Dive

Thu, 09/12/24 - 11:36 am

Novo backs 'breakthrough' antifungal player's $60M round — with a focus on rare mold infections

Endpoints

Wed, 08/12/20 - 10:34 am

drug development